XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Balance Sheet Details
 3 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Details

5. Balance Sheet Details

Inventory consisted of the following (in thousands):

 

 

 

March 31,
2023

 

 

December 31,
2022

 

Finished goods

 

$

1,594

 

 

$

1,926

 

Work in process

 

 

4,251

 

 

 

4,427

 

Raw material

 

 

5,174

 

 

 

5,207

 

 

 

$

11,019

 

 

$

11,560

 

Reported as:

 

 

 

 

 

 

    Inventory

 

$

6,095

 

 

$

6,636

 

    Long-term inventory

 

 

4,924

 

 

 

4,924

 

    Total

 

$

11,019

 

 

$

11,560

 

Amount reported as long-term inventory consisted of raw materials as of March 31, 2023 and December 31, 2022. The Company has raw materials beyond a one year production plan that help limit the exposures from potential supply interruption. Those raw materials beyond the one year production plan were classified as long-term inventory.

Accrued liabilities consisted of the following (in thousands):

 

 

 

March 31,
2023

 

 

December 31,
2022

 

Accrued milestone and contingent payments

 

$

69,583

 

 

$

—

 

Accrued sales allowances

 

 

50,137

 

 

 

26,046

 

Accrued research and development services

 

 

33,656

 

 

 

35,048

 

Accrued compensation and benefits

 

 

21,192

 

 

 

28,023

 

Accrued consulting and professional fees

 

 

12,876

 

 

 

11,377

 

Current portion of lease liabilities

 

 

9,173

 

 

 

9,305

 

Other

 

 

10,262

 

 

 

3,085

 

 

 

$

206,879

 

 

$

112,884